Balaji Amines Ltd. (BSE: 530999) is a Solapur, Maharashtra-based company in the Amines and Amine Derivatives industry. With a market capitalisation of ₹6,695 Cr, it ranks #732 by market cap among the 6,137 Indian listed companies on FinBizNet, and #2 of 3 in Amines and Amine Derivatives. At ₹1,827.90 (as of 25 Oct 2026), the share price is 30.5% below its 52-week high of ₹2,629.80 and 88.8% above its 52-week low of ₹968.10. The share price is up 33.2% over one year and down 15.9% over three months.
| Current Price | ₹1,827.90 |
|---|---|
| Market Cap | ₹6,695 Cr |
| BSE Code | 530999 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Amines and Amine Derivatives |
| P/E Ratio | 38.6 |
| Return on Equity | 8.11% |
| Return on Assets | 5.30% |
| 52-Week Range | ₹968.10 – ₹2,629.80 |
| 1-Year Price Change | +33.2% |
| 3-Month Price Change | -15.9% |
| Beta (1Y) | 0.38 |
| Dividend Yield | 0.55% |
| Headquarters | Solapur, Maharashtra |
| Website | www.balajiamines.com |
| Revenue | ₹456 Cr |
|---|---|
| Net Profit | ₹78 Cr |
| Net Margin | 17.1% |
| EPS (Basic) | ₹23.13 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in
1. Amines & Speciality Chemicals (Including BSCPL - Subsidiary)-This segment offers amines and specialty chemicals. 2. Hotel Division-This segment operates hotels. 3. Unallocated-0 4. Inter-Segment Revenue-0
1. Amines & Speciality Chemicals-97.8% 2. Hotel-2.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Alkyl Amines Chemicals Ltd | ₹9,429 Cr | 50.7 | 12.26% | ₹528 Cr | -15.2% |
| Balaji Amines Ltd. | ₹6,695 Cr | 38.6 | 8.11% | ₹456 Cr | +33.2% |
| Indo Amines Ltd. | ₹1,043 Cr | 12.6 | 22.30% | ₹375 Cr | -9.5% |
Listed by market capitalisation. Ratios are shown for context only.
Balaji Amines Ltd. is trading at ₹1,827.90, with a market capitalisation of ₹6,695 Cr.
Balaji Amines Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Amines and Amine Derivatives).
Balaji Amines Ltd. has a P/E of 38.6 and a return on equity of 8.11%.
Balaji Amines Ltd. is listed on the BSE under the scrip code 530999.
Balaji Amines Ltd.'s share price is up 33.2% over one year and down 15.9% over three months. Its 52-week range is ₹968.10 to ₹2,629.80.
In Q1 FY27, Balaji Amines Ltd. reported revenue of ₹456 Cr and net profit of ₹78 Cr, with basic EPS of ₹23.13 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.